Johnson & Johnson has agreed to a proposed $5.5 billion deal to settle about 76,000 baby powder ovarian cancer claims in the United States. The agreement could close a decade-long talc litigation battle if 95% of claimants accept it.

Johnson & Johnson announces a $5.5 billion settlement to resolve nearly 69,000 talc-related lawsuits alleging cancer risks.

Johnson & Johnson announces a $5.5 billion settlement to resolve nearly 69,000 talc-related lawsuits alleging cancer risks.

Johnson & Johnson said it would pay $5.5 billion to resolve tens of ⁠thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a landmark settlement aimed at closing a chapter of contentious litigation that has dogged the company for years.

The settlement covers claims alleging that J&J's talc products cause ovarian cancer. Read more at straitstimes.com. Read more at straitstimes.com.

The settlement covers claims alleging that J&J's talc products cause ovarian cancer. Read more at straitstimes.com. Read more at straitstimes.com.

NEW YORK: Johnson & Johnson said on Monday (Jul 27) it would pay US$5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a landmark settlement aimed at closing a chapter of contentious litigation that has dogged the company for years.

NEW YORK: Johnson & Johnson said on Monday (Jul 27) it would pay US$5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a landmark settlement aimed at closing a chapter of contentious litigation that has dogged the company for years.

NEW YORK: Johnson & Johnson said on Monday (Jul 27) it would pay US$5.5 billion to resolve tens of thousands of lawsuits alleging its baby powder and other talc products cause ovarian cancer, in a landmark settlement aimed at closing a chapter of contentious litigation that has dogged the company for years.